Health knowledge made personal
Home
Communities
WellPages
Resources Near You
WellTools
My Wellsphere
Sign Up!
•
Log in
Overview
Blog Posts
Discussions
People
More
Latest Activity
News
Pictures
Twitter Updates
Videos
Join this community!
+ Add Cancer to My Feeds
+ Bookmark page
› Share page:
All
HealthBloggers
Go
Search posts:
By
Cancer.gov
Blog:
http://www.cancer.gov
+ Add Blog to My Feeds
› View Profile
› Send a message
› Write on Whiteboard
More from this Member
•
Can Cancer Be Controlled?: National Cancer Institute Science Writers' Seminar
•
News Note: In Women, Abnormal Protein Associated with Myeloma Risk Now Linked to Obesity, Race
•
NIH Announces Ten Awards for Centers for Population Health and Health Disparities
•
Trends Suggest Increase in Cancers of the Lower Stomach for Younger Whites in U.S.
•
News Note: Multi-center Study Validates ProPSA Test for Early Detection of Prostate Cancer
» View All
Romidepsin for T-Cell Lymphoma
Posted Feb 22 2011 11:14pm
Report this
Share article
Bookmark article
Related Articles
FDA Approves First Drug for Treatment of Peripheral T-cell Lymphoma
Romidepsin for T-Cell Lymphoma
Drug Slows Progression of Cutaneous T-Cell Lymphoma
Romidepsin Reduces Disease Burden and Skin Symptoms in Patients with Previously Treated Cutaneous T-Cell Lymphoma
Interferon and arsenic tri-oxide for T-cell leukemia/ lymphoma
Ugly Cell: Diffuse Large B-Cell Lymphoma in the Brain
Anaplastic Large Cell Lymphoma (ALCL) in Women with Breast Implants: Preliminary FDA Findings and Analyses
Revlimid for refractory relapsed B-cell lymphoma
Have there been any studies done using solar treatment for mantle cell lymphoma?
Revlimid for mantle cell lymphoma
Post a comment
Post comment
Write a comment:
Post comment
Cancel
Ask
About Health Mavens
Related Searches
cell t cell lymphoma
t cell lymphoma
cutaneous t cell lymphoma
subcutaneous t cell lymphoma
hodgkins t cell lymphoma
causes of t cell lymphoma
untreated celiac disease and enteropathy associated t cell lymphoma
feline skin cancer
radiation for throat cancer
survival rates for stage ii ovarian cancer